New hope for lung cancer patients: drug combo targets tumors after treatment failure

This study tests a new drug called sunvozertinib combined with chemotherapy in people with advanced non-small cell lung cancer that has specific EGFR mutations. Participants must have already tried and failed an EGFR-targeted therapy. The goal is to see if the combination can shrink tumors and control the cancer for as long as possible.